Published in J Infect Dis on May 31, 2005
Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study. Lancet (2009) 4.76
Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait. Nat Genet (2005) 4.22
Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases. Nat Rev Immunol (2008) 4.12
Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study. Lancet (2011) 3.78
Decomposing health: tolerance and resistance to parasites in animals. Philos Trans R Soc Lond B Biol Sci (2009) 3.40
Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med (2011) 3.35
Sickle cell trait is associated with a delayed onset of malaria: implications for time-to-event analysis in clinical studies of malaria. J Infect Dis (2008) 2.77
Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis. Lancet Infect Dis (2012) 2.49
Heritability of malaria in Africa. PLoS Med (2005) 2.49
Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin. Proc Natl Acad Sci U S A (2008) 2.19
Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Natl Acad Sci U S A (2007) 2.07
Parasite burden and severity of malaria in Tanzanian children. N Engl J Med (2014) 2.07
Malaria as a cause of morbidity and mortality in children with homozygous sickle cell disease on the coast of Kenya. Clin Infect Dis (2009) 1.74
The effect of alpha+-thalassaemia on the incidence of malaria and other diseases in children living on the coast of Kenya. PLoS Med (2006) 1.73
Hemoglobin S and C heterozygosity enhances neither the magnitude nor breadth of antibody responses to a diverse array of Plasmodium falciparum antigens. J Infect Dis (2011) 1.71
Glucose-6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children in Kenya: a case-control and a cohort study. Lancet Haematol (2015) 1.56
Risk factors for mortality from imported falciparum malaria in the United Kingdom over 20 years: an observational study. BMJ (2012) 1.54
Experiences with community engagement and informed consent in a genetic cohort study of severe childhood diseases in Kenya. BMC Med Ethics (2010) 1.54
World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb Perspect Med (2012) 1.47
High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya. Blood (2010) 1.44
Evidence for over-dispersion in the distribution of clinical malaria episodes in children. PLoS One (2008) 1.44
A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus. Proc Natl Acad Sci U S A (2010) 1.41
Sickle cell disease in Africa: burden and research priorities. Ann Trop Med Parasitol (2007) 1.41
Malaria's indirect contribution to all-cause mortality in the Andaman Islands during the colonial era. Lancet Infect Dis (2008) 1.40
Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization. Blood (2009) 1.40
'All her children are born that way': gendered experiences of stigma in families affected by sickle cell disorder in rural Kenya. Ethn Health (2011) 1.38
Hematological predictors of increased severe anemia in Kenyan children coinfected with Plasmodium falciparum and HIV-1. Am J Hematol (2010) 1.30
The quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria. PLoS One (2009) 1.24
Sickle-cell trait: novel clinical significance. Hematology Am Soc Hematol Educ Program (2010) 1.23
Genetic determination and linkage mapping of Plasmodium falciparum malaria related traits in Senegal. PLoS One (2008) 1.20
Evidence for both innate and acquired mechanisms of protection from Plasmodium falciparum in children with sickle cell trait. Blood (2012) 1.13
HMOX1 gene promoter alleles and high HO-1 levels are associated with severe malaria in Gambian children. PLoS Pathog (2012) 1.13
Genome-wide linkage analysis of malaria infection intensity and mild disease. PLoS Genet (2007) 1.13
Framing the research agenda for sickle cell trait: building on the current understanding of clinical events and their potential implications. Am J Hematol (2012) 1.10
The burden and consequences of inherited blood disorders among young children in western Kenya. Matern Child Nutr (2012) 1.08
Abnormal PfEMP1/knob display on Plasmodium falciparum-infected erythrocytes containing hemoglobin variants: fresh insights into malaria pathogenesis and protection. Microbes Infect (2012) 1.03
Hemoglobin cleavage site-specificity of the Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3. PLoS One (2009) 1.02
Haplotype association between haptoglobin (Hp2) and Hp promoter SNP (A-61C) may explain previous controversy of haptoglobin and malaria protection. PLoS One (2007) 0.99
Host erythrocyte polymorphisms and exposure to Plasmodium falciparum in Papua New Guinea. Malar J (2008) 0.95
Transforming growth factor beta 2 and heme oxygenase 1 genes are risk factors for the cerebral malaria syndrome in Angolan children. PLoS One (2010) 0.94
Heme cytotoxicity and the pathogenesis of immune-mediated inflammatory diseases. Front Pharmacol (2012) 0.94
Biochemical and immunological mechanisms by which sickle cell trait protects against malaria. Malar J (2013) 0.92
Associations between red cell polymorphisms and Plasmodium falciparum infection in the middle belt of Ghana. PLoS One (2014) 0.90
Interpreting malaria age-prevalence and incidence curves: a simulation study of the effects of different types of heterogeneity. Malar J (2010) 0.90
Cytoadherence in paediatric malaria: ABO blood group, CD36, and ICAM1 expression and severe Plasmodium falciparum infection. Br J Haematol (2012) 0.89
Hemoglobin E and Glucose-6-Phosphate Dehydrogenase Deficiency and Plasmodium falciparum Malaria in the Chittagong Hill Districts of Bangladesh. Am J Trop Med Hyg (2015) 0.89
A co-evolutionary arms race: trypanosomes shaping the human genome, humans shaping the trypanosome genome. Parasitology (2015) 0.89
Mechanistic Studies of the Negative Epistatic Malaria-protective Interaction Between Sickle Cell Trait and α(+)thalassemia. EBioMedicine (2014) 0.88
Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case-control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer. Int J Cancer (2013) 0.88
Role of cellular iron and oxygen in the regulation of HIV-1 infection. Future Virol (2013) 0.86
Negative epistasis between α+ thalassaemia and sickle cell trait can explain interpopulation variation in South Asia. Evolution (2011) 0.86
Haemoglobin variants and Plasmodium falciparum malaria in children under five years of age living in a high and seasonal malaria transmission area of Burkina Faso. Malar J (2012) 0.86
Malaria continues to select for sickle cell trait in Central Africa. Proc Natl Acad Sci U S A (2015) 0.85
Uncertainty in mapping malaria epidemiology: implications for control. Epidemiol Rev (2010) 0.85
The genetic risk of acute seizures in African children with falciparum malaria. Epilepsia (2013) 0.84
The V gene repertoires of classical and atypical memory B cells in malaria-susceptible West African children. J Immunol (2015) 0.84
Transition-state inhibitors of purine salvage and other prospective enzyme targets in malaria. Future Med Chem (2013) 0.83
Heterogeneous alleles comprising G6PD deficiency trait in West Africa exert contrasting effects on two major clinical presentations of severe malaria. Malar J (2016) 0.82
Cytokine profiles at birth predict malaria severity during infancy. PLoS One (2013) 0.82
Effects of age, hemoglobin type and parasite strain on IgG recognition of Plasmodium falciparum-infected erythrocytes in Malian children. PLoS One (2013) 0.82
The emergence and maintenance of sickle cell hotspots in the Mediterranean. Infect Genet Evol (2012) 0.81
Sickle cell trait (HbAS) and stunting in children below two years of age in an area of high malaria transmission. Malar J (2009) 0.80
Frequencies of peripheral blood myeloid cells in healthy Kenyan children with alpha+ thalassemia and the sickle cell trait. Am J Trop Med Hyg (2006) 0.80
A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease. Expert Rev Hematol (2015) 0.80
Hemoglobin S and C affect protein export in Plasmodium falciparum-infected erythrocytes. Biol Open (2015) 0.79
Hemoglobin C Trait Provides Protection From Clinical Falciparum Malaria in Malian Children. J Infect Dis (2015) 0.77
Negative health implications of sickle cell trait in high income countries: from the football field to the laboratory. Br J Haematol (2015) 0.77
Influence of Sickle Cell Gene on the Allelic Diversity at the msp-1 locus of Plasmodium falciparum in Adult Patients with Severe Malaria. Mediterr J Hematol Infect Dis (2015) 0.77
Haptoglobin and sickle cell polymorphisms and risk of active trachoma in Gambian children. PLoS One (2010) 0.77
An evolving picture of the interactions between malaria parasites and their host erythrocytes. Cell Res (2012) 0.76
Genetics and the general physician: insights, applications and future challenges. QJM (2009) 0.76
Falciparum malaria infection in a case of sickle cell trait; unbalancing the balanced polymorphism. Indian J Hematol Blood Transfus (2012) 0.75
Maternal anaemia at delivery and haemoglobin evolution in children during their first 18 months of life using latent class analysis. PLoS One (2012) 0.75
Travelers with sickle cell disease. J Travel Med (2014) 0.75
Assessing the impact of differences in malaria transmission intensity on clinical and haematological indices in children with malaria. Malar J (2017) 0.75
An Expert Review of Pharmacogenomics of Sickle Cell Disease Therapeutics: Not Yet Ready for Global Precision Medicine. OMICS (2016) 0.75
Recent insights into the population genetics and dynamics of the inherited disorders of hemoglobin. Mediterr J Hematol Infect Dis (2009) 0.75
Quantitative trait locus analysis of parasite density reveals that HbS gene carriage protects severe malaria patients against Plasmodium falciparum hyperparasitaemia. Malar J (2015) 0.75
Major Histocompatibility Complex and Malaria: Focus on Plasmodium vivax Infection. Front Immunol (2016) 0.75
Evolutionary medicine: update on the relevance to family practice. Can Fam Physician (2008) 0.75
The use of partial exchange blood transfusion and anaesthesia in the management of sickle cell disease in a perioperative setting: two case reports. J Med Case Rep (2010) 0.75
Red blood cell complement receptor one level varies with Knops blood group, α(+)thalassaemia and age among Kenyan children. Genes Immun (2016) 0.75
Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research. Blood (2016) 0.75
Preparing for future efficacy trials of severe malaria vaccines. Vaccine (2016) 0.75
Mutation Spectrum of STAR and a Founder Effect of the p.Q258* in Korean Patients with Congenital Lipoid Adrenal Hyperplasia. Mol Med (2017) 0.75
Relationships between sickle cell trait, malaria, and educational outcomes in Tanzania. BMC Infect Dis (2017) 0.75
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet (1997) 25.40
Selected major risk factors and global and regional burden of disease. Lancet (2002) 24.47
Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med (2005) 13.27
Indicators of life-threatening malaria in African children. N Engl J Med (1995) 13.17
Protection afforded by sickle-cell trait against subtertian malareal infection. Br Med J (1954) 11.13
Common west African HLA antigens are associated with protection from severe malaria. Nature (1991) 9.43
Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis (2002) 6.73
Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Trans R Soc Trop Med Hyg (1987) 6.58
Insecticide-treated bednets reduce mortality and severe morbidity from malaria among children on the Kenyan coast. Trop Med Int Health (1996) 5.87
Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet (1997) 5.59
Attributable fraction estimates and case definitions for malaria in endemic areas. Stat Med (1994) 5.58
Severe and complicated malaria. World Health Organization, Division of Control of Tropical Diseases. Trans R Soc Trop Med Hyg (1990) 4.95
Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans R Soc Trop Med Hyg (1990) 4.70
The effects of malnutrition on child mortality in developing countries. Bull World Health Organ (1995) 4.52
Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet (2002) 4.13
Malaria-related anaemia. Parasitol Today (2000) 3.18
Effects of heavy and repeated malarial infections on Gambian infants and children; effects of erythrocytic parasitization. Br Med J (1956) 2.97
Comparison of two strategies for control of malaria within a primary health care programme in the Gambia. Lancet (1988) 2.83
The variability of sickle-cell rates in the tribes of Kenya and the Southern Sudan. Br Med J (1954) 2.77
POLYMORPHISM AND NATURAL SELECTION IN HUMAN POPULATIONS. Cold Spring Harb Symp Quant Biol (1964) 2.55
Cellular mechanism for the protective effect of haemoglobin S against P. falciparum malaria. Nature (1978) 2.28
alpha+-Thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci U S A (1997) 2.19
Erythrocytic mechanism of sickle cell resistance to malaria. Proc Natl Acad Sci U S A (1978) 2.14
Increased sickling of parasitised erythrocytes as mechanism of resistance against malaria in the sickle-cell trait. Lancet (1970) 2.11
Abnormal haemoglobins in the Sudan savanna of Nigeria. I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival. Ann Trop Med Parasitol (1979) 2.07
Malaria and nutritional status in children living on the coast of Kenya. Am J Clin Nutr (2004) 1.90
The effect of delivery mechanisms on the uptake of bed net re-impregnation in Kilifi District, Kenya. Health Policy Plan (1999) 1.79
A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 6. The impact of the interventions on mortality and morbidity from malaria. Trans R Soc Trop Med Hyg (1993) 1.79
Malaria and mortality: some epidemiological considerations. Ann Trop Med Parasitol (1997) 1.74
Paediatric survival and re-admission risks following hospitalization on the Kenyan coast. Trop Med Int Health (2000) 1.73
The anaemia of Plasmodium falciparum malaria. Br Med Bull (1982) 1.59
The etiology of severe anemia in a village and a periurban area in Mali. Blood (2004) 1.55
Glucose-6-phosphate-dehydrogenase deficiency, sickling, and malaria in African children in South Western Nigeria. Lancet (1967) 1.50
Sickling rates of human AS red cells infected in vitro with Plasmodium falciparum malaria. Science (1978) 1.31
Magnitude of the problem of childhood pneumonia. Lancet (1999) 1.27
A case-control study in northern Liberia of Plasmodium falciparum malaria in haemoglobin S and beta-thalassaemia traits. Ann Trop Med Parasitol (1983) 1.24
Changes in the pattern of mortality following the eradication of hyperendemic malaria from a highly susceptible community. Bull World Health Organ (1972) 1.23
Longitudinal study of Plasmodium falciparum infection and immune responses in infants with or without the sickle cell trait. Int J Epidemiol (1999) 1.16
Transgenic mice expressing human sickle hemoglobin are partially resistant to rodent malaria. Blood (1993) 1.04
Innate resistance to malaria: the intraerythrocytic cycle. Blood Cells (1990) 1.02
Cell-mediated immune responses to Plasmodium falciparum purified soluble antigens in sickle-cell trait subjects. Immunol Lett (1990) 1.00
Sickle cell disease in the Balovale District of Northern Rhodesia. East Afr Med J (1946) 0.98
Effect of sickle-cell trait on resistance to malaria. Br Med J (1955) 0.96
Plasmodium falciparum: physiological interactions with the human sickle cell. Exp Parasitol (1979) 0.96
Impact of permethrin-treated bed nets on growth, nutritional status, and body composition of primary school children in western Kenya. Am J Trop Med Hyg (2003) 0.95
Sickle hemoglobin instability: a mechanism for malarial protection. Redox Rep (2003) 0.94
Malaria: nutritional implications. Rev Infect Dis (1982) 0.89
Seasonal changes in cell mediated immune responses to soluble Plasmodium falciparum antigens in children with haemoglobin AA and haemoglobin AS. Trans R Soc Trop Med Hyg (1992) 0.88
Sickle cell disease in Northern Rhodesia. East Afr Med J (1947) 0.86
The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis (2004) 14.42
Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med (2005) 13.27
A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med (2009) 12.82
Urbanization, malaria transmission and disease burden in Africa. Nat Rev Microbiol (2005) 11.88
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
The pathogenic basis of malaria. Nature (2002) 10.44
The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. PLoS Med (2008) 8.95
Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet (2008) 8.50
Shrinking the malaria map: progress and prospects. Lancet (2010) 8.21
Effect of expanded insecticide-treated bednet coverage on child survival in rural Kenya: a longitudinal study. Lancet (2007) 7.98
Satellite imagery in the study and forecast of malaria. Nature (2002) 7.84
Climate change and the resurgence of malaria in the East African highlands. Nature (2002) 7.70
The decline in paediatric malaria admissions on the coast of Kenya. Malar J (2007) 7.45
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med (2008) 7.28
Estimating the global clinical burden of Plasmodium falciparum malaria in 2007. PLoS Med (2010) 7.22
Improved diagnostic testing and malaria treatment practices in Zambia. JAMA (2007) 7.15
Assessment of inpatient paediatric care in first referral level hospitals in 13 districts in Kenya. Lancet (2004) 7.13
Increasing coverage and decreasing inequity in insecticide-treated bed net use among rural Kenyan children. PLoS Med (2007) 6.92
Insecticide-treated net coverage in Africa: mapping progress in 2000-07. Lancet (2008) 6.91
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
The burden of malaria mortality among African children in the year 2000. Int J Epidemiol (2006) 6.64
Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis (2008) 6.53
Operational strategies to achieve and maintain malaria elimination. Lancet (2010) 6.48
The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis (2010) 6.23
The consequences of reducing transmission of Plasmodium falciparum in Africa. Adv Parasitol (2002) 6.01
Scaling-up coverage with insecticide-treated nets against malaria in Africa: who should pay? Lancet Infect Dis (2003) 5.74
Immunity to malaria: more questions than answers. Nat Immunol (2008) 5.71
The malaria Atlas Project: developing global maps of malaria risk. PLoS Med (2006) 5.51
The effect of mobile phone text-message reminders on Kenyan health workers' adherence to malaria treatment guidelines: a cluster randomised trial. Lancet (2011) 5.42
Revisiting the basic reproductive number for malaria and its implications for malaria control. PLoS Biol (2007) 5.40
Forecasting, warning, and detection of malaria epidemics: a case study. Lancet (2003) 5.27
Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med (2010) 4.89
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. Malar J (2007) 4.85
Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J Exp Med (2004) 4.76
Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study. Lancet (2009) 4.76
Quantifying the impact of human mobility on malaria. Science (2012) 4.60
Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya. J Infect Dis (2005) 4.44
Mapping the global extent of malaria in 2005. Trends Parasitol (2006) 4.43
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature (2012) 4.37
Population distribution, settlement patterns and accessibility across Africa in 2010. PLoS One (2012) 4.34
Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet (2009) 4.30
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet (2007) 4.23
Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait. Nat Genet (2005) 4.22
Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study. Malar J (2007) 4.21
Delivery of paediatric care at the first-referral level in Kenya. Lancet (2004) 4.16
Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. Lancet Infect Dis (2003) 4.10
Ranking of elimination feasibility between malaria-endemic countries. Lancet (2010) 4.05
Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res (2009) 3.99
Standardizing estimates of the Plasmodium falciparum parasite rate. Malar J (2007) 3.87
Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study. BMJ (2005) 3.80
Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study. Lancet (2011) 3.78
Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya. PLoS Med (2010) 3.78
Malaria case-management under artemether-lumefantrine treatment policy in Uganda. Malar J (2008) 3.73
Defining and detecting malaria epidemics in the highlands of western Kenya. Emerg Infect Dis (2002) 3.55
Improving imperfect data from health management information systems in Africa using space-time geostatistics. PLoS Med (2006) 3.53
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun (2008) 3.51
Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. Vaccine (2004) 3.51
Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev (2004) 3.45
Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project. Malar J (2007) 3.42
Use of clinical syndromes to target antibiotic prescribing in seriously ill children in malaria endemic area: observational study. BMJ (2005) 3.34
CISH and susceptibility to infectious diseases. N Engl J Med (2010) 3.31
Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children. JAMA (2007) 3.29
Epidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control. Am J Trop Med Hyg (2007) 3.29
Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine. Malar J (2008) 3.25
Predicting changing malaria risk after expanded insecticide-treated net coverage in Africa. Trends Parasitol (2009) 3.25
Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet (2004) 3.25
Modelling distances travelled to government health services in Kenya. Trop Med Int Health (2006) 3.22
Malaria prevention in highland Kenya: indoor residual house-spraying vs. insecticide-treated bednets. Trop Med Int Health (2002) 3.20
Malaria misdiagnosis in Uganda--implications for policy change. Malar J (2009) 3.19
The use of formal and informal curative services in the management of paediatric fevers in four districts in Kenya. Trop Med Int Health (2003) 3.19
Effect of malaria rapid diagnostic tests on the management of uncomplicated malaria with artemether-lumefantrine in Kenya: a cluster randomized trial. Am J Trop Med Hyg (2009) 3.17
Hot topic or hot air? Climate change and malaria resurgence in East African highlands. Trends Parasitol (2002) 3.10
Climate change and the global malaria recession. Nature (2010) 3.10
How absolute is zero? An evaluation of historical and current definitions of malaria elimination. Malar J (2010) 3.05
Meteorologic influences on Plasmodium falciparum malaria in the Highland Tea Estates of Kericho, Western Kenya. Emerg Infect Dis (2002) 3.02
Malaria drug shortages in Kenya: a major failure to provide access to effective treatment. Am J Trop Med Hyg (2009) 2.84
Impact of malaria control on childhood anaemia in Africa -- a quantitative review. Trop Med Int Health (2004) 2.80
HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria. Clin Infect Dis (2009) 2.80
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial. Lancet Infect Dis (2011) 2.79
Heterogeneous mobile phone ownership and usage patterns in Kenya. PLoS One (2012) 2.78
Modelling the global constraints of temperature on transmission of Plasmodium falciparum and P. vivax. Parasit Vectors (2011) 2.78
The risks of malaria infection in Kenya in 2009. BMC Infect Dis (2009) 2.76
Clinical features and pathogenesis of severe malaria. Trends Parasitol (2004) 2.73
The use of mosquito nets and the prevalence of Plasmodium falciparum infection in rural South Central Somalia. PLoS One (2008) 2.72
Clinical epidemiology of malaria in the highlands of western Kenya. Emerg Infect Dis (2002) 2.69
Clinical research in resource-limited settings: enhancing research capacity and working together to make trials less complicated. PLoS Negl Trop Dis (2010) 2.68
Profile: The Kilifi Health and Demographic Surveillance System (KHDSS). Int J Epidemiol (2012) 2.64
Global warming and malaria: a call for accuracy. Lancet Infect Dis (2004) 2.63
Coverage of malaria protection in pregnant women in sub-Saharan Africa: a synthesis and analysis of national survey data. Lancet Infect Dis (2011) 2.60
Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. Emerg Infect Dis (2010) 2.59
Transient cross-reactive immune responses can orchestrate antigenic variation in malaria. Nature (2004) 2.56
An updated atlas of human helminth infections: the example of East Africa. Int J Health Geogr (2009) 2.54
Heritability of malaria in Africa. PLoS Med (2005) 2.49